An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey

dc.authoridTAYLAN, GOKAY/0000-0002-7015-4537
dc.authoridMemic Sancar, Kadriye/0000-0003-1350-215X
dc.authoridAltuntaş, Emine/0000-0001-5887-5422
dc.authoridBAŞARAN, ÖZCAN/0000-0002-6384-6455
dc.authorwosidTAYLAN, GOKAY/HJZ-4693-2023
dc.authorwosidMemic Sancar, Kadriye/GVU-1673-2022
dc.authorwosidAslan, Onur/GRJ-0692-2022
dc.authorwosiddemirci, erkan/IVH-2862-2023
dc.authorwosidAltuntaş, Emine/HGE-0409-2022
dc.authorwosidKalkan, Sedat/GWN-0098-2022
dc.authorwosidorscelik, özcan/A-6242-2016
dc.contributor.authorSancar, Kadriye Memic
dc.contributor.authorCelik, Oguzhan
dc.contributor.authorCil, Cem
dc.contributor.authorKaraarslan, Osman
dc.contributor.authorDogan, Tolga
dc.contributor.authorYetim, Mucahit
dc.contributor.authorAsoglu, Ramazan
dc.date.accessioned2024-06-12T10:52:37Z
dc.date.available2024-06-12T10:52:37Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial has been the largest study ever conducted among patients in Turkey regarding aspirin treatment. In the subgroup analysis of the hypertensive group of the Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial, we aimed to evaluate the physicians' adherence to current guidelines regarding their aspirin treatment preferences. Methods: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial is a cross-sectional and multicenter study conducted among 5007 consecutive patients aged >= 18 years. The study population consisted of outpatients on aspirin treatment (80-300 mg). The patient data were obtained from 30 different cardiology clinics of 14 cities from all over Turkey. In this subgroup analysis, patients were divided into 2 groups: the hypertensive group (n=3467, 69.3%) and the group without hypertension (n =1540, 30.7%) according to the 2018 European Society of Cardiology/ European Society of Hypertension Guidelines for the Management of Arterial Hypertension. Results: Aspirin usefor primary prevention was higher in patients with hypertension compared to patients without hypertension [328 (21.3%); 1046 (30.2%); P < .0011. Treatment with a dose of 150 mg aspirin (n=172, 5%) was mostly preferred by internists for hypertensive patients (n =226, 6.5%); however, a daily dose of 80-100 mg aspirin therapy (n =1457, 94.6%) was mostly prescribed by cardiologists (n =1347, 87.5%) for patients without hypertension. Conclusion: Aspirin was found to be used commonly among patients with hypertension for primary prevention despite the current European Society of Cardiology Arterial Hypertension Guideline not recommending aspirin for primary prevention in patients with hypertension.en_US
dc.identifier.doi10.5152/AnatolJCardiol.2021.541
dc.identifier.endpage268en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85128793460en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage260en_US
dc.identifier.trdizinid519385en_US
dc.identifier.urihttps://doi.org/10.5152/AnatolJCardiol.2021.541
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/519385
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18778
dc.identifier.volume26en_US
dc.identifier.wosWOS:000791808300004en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofAnatolian Journal Of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAspirinen_US
dc.subjectHypertensionen_US
dc.subjectPrimary Preventionen_US
dc.subjectSecondary Preventionen_US
dc.subjectTurkeyen_US
dc.subjectLow-Dose Aspirinen_US
dc.subjectHealth-Care Professionalsen_US
dc.subjectCardiovascular-Diseaseen_US
dc.subjectPrimary Preventionen_US
dc.subjectAntiplatelet Therapyen_US
dc.subjectBlood-Pressureen_US
dc.subjectMetaanalysisen_US
dc.subjectStatementen_US
dc.subjectStrokeen_US
dc.titleAn Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkeyen_US
dc.typeArticleen_US

Dosyalar